Redefining possibilities with SHL’s new reusable electromechanical autoinjector
In the October issue of ONdrug Delivery magazine, SHL Medical’s Vince Masciopinto introduces Elexy™, our reusable electromechanical autoinjector designed to support combination product development at every stage—preclinical, clinical, and commercial. The article details how Elexy delivers a broad range of injection profiles with the simplicity of loading a new drug cassette, making it a versatile solution for evolving drug delivery needs.
As the landscape of parenteral drug delivery shifts, the demand for devices that address unmet needs in both product development and patient care grows. Managing parameters such as injection volume, rate, and viscosity with single-use mechanical devices can be expensive and time-consuming, especially for chronic conditions requiring multiple or variable doses. Elexy supports the simplification of this process, offering a streamlined solution for patients and developers alike.
The article highlights Elexy’s key strengths – flexibility, reusability, connectivity, and ease of use – to address critical challenges across development and commercial stages. In preclinical studies, Elexy can support flexible experimental design for evaluating injection performance. During clinical trials, Elexy can allow for a seamless transition from trial to commercial use, reducing development risk and lifecycle management costs while accelerating time-to-market.
At the commercial stage, Elexy’s reusable power unit offers potential advantages for dynamic treatment plans. Whether patients require variable doses or multi-dose therapies, the device ensures a consistent user experience across every injection. Its RFID-enabled drug cassettes are designed to provide accurate delivery parameters without user intervention, and its multi-level feedback mechanisms can further enhance usability and minimize the risk of user errors. Download and read the full article for a deeper dive on what Elexy has to offer.
As the pioneering leader in the self-injection space, SHL Medical continues to lead the way in developing innovative solutions for both pharma and patients. Elexy, with its wide range of injection profiles and best-in-class user experience, is set to redefine possibilities for injectable drug delivery.
